Copyright Reports & Markets. All rights reserved.

Global Prostate Cancer Diagnostics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Prostate Cancer Diagnostics Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Overview: Global Prostate Cancer Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Tumor Biomarker Tests
      • 1.2.3 Imaging
      • 1.2.4 Biopsy
      • 1.2.5 Other
    • 1.3 Market Analysis by Application
      • 1.3.1 Overview: Global Prostate Cancer Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 age < 55
      • 1.3.3 age 55-75
      • 1.3.4 age > 75
    • 1.4 Overview of Global Prostate Cancer Diagnostics Market
      • 1.4.1 Global Prostate Cancer Diagnostics Market Status and Outlook (2015-2025)
      • 1.4.2 North America (United States, Canada and Mexico)
      • 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
      • 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      • 1.4.5 South America, Middle East & Africa
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Genomic Health
      • 2.1.1 Genomic Health Details
      • 2.1.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Genomic Health SWOT Analysis
      • 2.1.4 Genomic Health Product and Services
      • 2.1.5 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 MDx Health
      • 2.2.1 MDx Health Details
      • 2.2.2 MDx Health Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 MDx Health SWOT Analysis
      • 2.2.4 MDx Health Product and Services
      • 2.2.5 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Siemens Healthcare
      • 2.3.1 Siemens Healthcare Details
      • 2.3.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Siemens Healthcare SWOT Analysis
      • 2.3.4 Siemens Healthcare Product and Services
      • 2.3.5 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Abbott
      • 2.4.1 Abbott Details
      • 2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Abbott SWOT Analysis
      • 2.4.4 Abbott Product and Services
      • 2.4.5 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Roche
      • 2.5.1 Roche Details
      • 2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Roche SWOT Analysis
      • 2.5.4 Roche Product and Services
      • 2.5.5 Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 OPKO
      • 2.6.1 OPKO Details
      • 2.6.2 OPKO Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 OPKO SWOT Analysis
      • 2.6.4 OPKO Product and Services
      • 2.6.5 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Myriad Genetics
      • 2.7.1 Myriad Genetics Details
      • 2.7.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Myriad Genetics SWOT Analysis
      • 2.7.4 Myriad Genetics Product and Services
      • 2.7.5 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 BioMeriux
      • 2.8.1 BioMeriux Details
      • 2.8.2 BioMeriux Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 BioMeriux SWOT Analysis
      • 2.8.4 BioMeriux Product and Services
      • 2.8.5 BioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 DiaSorin
      • 2.9.1 DiaSorin Details
      • 2.9.2 DiaSorin Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 DiaSorin SWOT Analysis
      • 2.9.4 DiaSorin Product and Services
      • 2.9.5 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Beckman Coulter
      • 2.10.1 Beckman Coulter Details
      • 2.10.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Beckman Coulter SWOT Analysis
      • 2.10.4 Beckman Coulter Product and Services
      • 2.10.5 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Ambry Genetics
      • 2.11.1 Ambry Genetics Details
      • 2.11.2 Ambry Genetics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Ambry Genetics SWOT Analysis
      • 2.11.4 Ambry Genetics Product and Services
      • 2.11.5 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

    3 Sales, Revenue and Market Share by Manufacturer

    • 3.1 Global Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2018-2019)
    • 3.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2018-2019)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Prostate Cancer Diagnostics Manufacturer Market Share in 2019
      • 3.3.2 Top 6 Prostate Cancer Diagnostics Manufacturer Market Share in 2019
    • 3.4 Market Competition Trend

    4 Global Market Analysis by Regions

    • 4.1 Global Prostate Cancer Diagnostics Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Prostate Cancer Diagnostics Sales and Market Share by Regions (2015-2020)
      • 4.1.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Regions (2015-2020)
    • 4.2 North America Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 4.3 Europe Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 4.5 South America Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 4.6 Middle East and Africa Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)

    5 North America by Country

    • 5.1 North America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
      • 5.1.1 North America Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
      • 5.1.2 North America Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
    • 5.2 United States Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 5.3 Canada Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 5.4 Mexico Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)

    6 Europe by Country

    • 6.1 Europe Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
      • 6.1.2 Europe Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
    • 6.2 Germany Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 6.3 UK Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 6.4 France Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 6.5 Russia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 6.6 Italy Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)

    7 Asia-Pacific by Regions

    • 7.1 Asia-Pacific Prostate Cancer Diagnostics Sales, Revenue and Market Share by Regions
      • 7.1.1 Asia-Pacific Prostate Cancer Diagnostics Sales and Market Share by Regions (2015-2020)
      • 7.1.2 Asia-Pacific Prostate Cancer Diagnostics Revenue and Market Share by Regions (2015-2020)
    • 7.2 China Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 7.3 Japan Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 7.4 Korea Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 7.5 India Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 7.7 Australia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)

    8 South America by Country

    • 8.1 South America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
      • 8.1.1 South America Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
      • 8.1.2 South America Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
    • 8.2 Brazil Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 8.3 Argentina Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)

    9 Middle East & Africa by Countries

    • 9.1 Middle East & Africa Prostate Cancer Diagnostics Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East & Africa Prostate Cancer Diagnostics Sales and Market Share by Country (2015-2020)
      • 9.1.2 Middle East & Africa Prostate Cancer Diagnostics Revenue and Market Share by Country (2015-2020)
    • 9.2 Saudi Arabia Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 9.3 Turkey Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 9.4 Egypt Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)
    • 9.5 South Africa Prostate Cancer Diagnostics Sales and Growth Rate (2015-2020)

    10 Market Segment by Type

    • 10.1 Global Prostate Cancer Diagnostics Sales and Market Share by Type (2015-2020)
    • 10.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2015-2020)
    • 10.3 Global Prostate Cancer Diagnostics Price by Type (2015-2020)

    11 Global Prostate Cancer Diagnostics Market Segment by Application

    • 11.1 Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
    • 11.2 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2015-2020)
    • 11.3 Global Prostate Cancer Diagnostics Price by Application (2015-2020)

    12 Market Forecast

    • 12.1 Global Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2021-2025)
    • 12.2 Prostate Cancer Diagnostics Market Forecast by Regions (2021-2025)
      • 12.2.1 North America Prostate Cancer Diagnostics Market Forecast (2021-2025)
      • 12.2.2 Europe Prostate Cancer Diagnostics Market Forecast (2021-2025)
      • 12.2.3 Asia-Pacific Prostate Cancer Diagnostics Market Forecast (2021-2025)
      • 12.2.4 South America Prostate Cancer Diagnostics Market Forecast (2021-2025)
      • 12.2.5 Middle East & Africa Prostate Cancer Diagnostics Market Forecast (2021-2025)
    • 12.3 Prostate Cancer Diagnostics Market Forecast by Type (2021-2025)
      • 12.3.1 Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2025)
      • 12.3.2 Global Prostate Cancer Diagnostics Market Share Forecast by Type (2021-2025)
    • 12.4 Prostate Cancer Diagnostics Market Forecast by Application (2021-2025)
      • 12.4.1 Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2025)
      • 12.4.2 Global Prostate Cancer Diagnostics Market Share Forecast by Application (2021-2025)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology
      • 15.2 Data Source
      • 15.3 Disclaimer

      Summary

      Market Overview
      The global Prostate Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0% in the forecast period of 2020 to 2025 and will expected to reach USD 15640 million by 2025, from USD 11940 million in 2019.
      The Prostate Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      Prostate Cancer Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
      By Type, Prostate Cancer Diagnostics market has been segmented into Tumor Biomarker Tests, Imaging, Biopsy, Other, etc.
      By Application, Prostate Cancer Diagnostics has been segmented into age < 55, age 55-75, age > 75, etc.
      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Cancer Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Cancer Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Cancer Diagnostics market.
      The report offers in-depth assessment of the growth and other aspects of the Prostate Cancer Diagnostics market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Prostate Cancer Diagnostics markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
      Competitive Landscape and Prostate Cancer Diagnostics Market Share Analysis
      Prostate Cancer Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Cancer Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Cancer Diagnostics sales, revenue and market share for each player covered in this report.
      The major players covered in Prostate Cancer Diagnostics are: Genomic Health, MDx Health, Siemens Healthcare, Abbott, Roche, OPKO, Myriad Genetics, BioMeriux, DiaSorin, Beckman Coulter, Ambry Genetics, etc. Among other players domestic and global, Prostate Cancer Diagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Prostate Cancer Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Prostate Cancer Diagnostics, with price, sales, revenue and global market share of Prostate Cancer Diagnostics in 2018 and 2019.
      Chapter 3, the Prostate Cancer Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Prostate Cancer Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
      Chapter 12, Prostate Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
      Chapter 13, 14 and 15, to describe Prostate Cancer Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now